|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 47/60 | (2017.01) | ||
| A61P 15/00 | (2006.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/08 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3299392 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17200006.9 |
| Date of filing the European patent application | 2012-10-04 | |
| (97) | Date of publication of the European application | 2018-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 11306353 | 2011-10-19 | EP |
| (72) |
BROUARD, Sophie, FR
MAI, Le Hoa, FR
MARY, Caroline, FR
POIRIER, Nicolas, FR
SOULILLOU, Jean-Paul, FR
VANHOVE, Bernard, FR
|
| (73) |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,
101, Rue de Tolbiac, 75654 Paris Cedex 13,
FR
OSE Immunotherapeutics, 22 Boulevard Benoni Goullin, 44200 Nantes, FR |
| (54) | ANTIBODIES DIRECTED AGAINST THE ALPHA CHAIN OF IL7 RECEPTOR - THEIR USE FOR THE PREPARATION OF DRUG CANDIDATES |
| ANTIBODIES DIRECTED AGAINST THE ALPHA CHAIN OF IL7 RECEPTOR - THEIR USE FOR THE PREPARATION OF DRUG CANDIDATES |